REFERENCES
- Lester, D., Lolli, G. and Greenberg, L. A.: The fate of acetylsalicylic acid. J. Pharmacol. & Exper. Therap. 87:329–342 (August) 1946.
- Gross, M. and Greenberg, L. A.: The Salicylates; a Critical Bibliographic Review. New Haven, Connecticut, Hillhouse Press, 1948.
- Smith, M. J. H.: Some recent advances in the pharmacology of salicylates; review article. J. Pharm. & Pharmacol. 5:81–93 (February) 1953.
- Drill, V. A.: Pharmacology in Medicine. New York, McGraw-Hill Book Company, Inc., 1954, chap. 20, pp. 1–17.
- Goodman, L. S. and Gilman, A.: The Pharmacological Basis of Therapeutics. Ed. 2. New York, The Macmillan Company, 1955, pp. 281–294.
- Mandel, H. G., Cambosos, N. M. and Smith, P. K.: The presence of aspirin in human plasma after oral administration. J. Pharmacol. & Exper. Therap. 112:249 (December) 1954.
- Paul, W. D.: The effect of acetylsalicylic acid (aspirin) on the gastric mucosa. J. Iowa M. Soc. 33:155 (April) 1943.
- Hardy, J. D. and Mckeen, C.: Measurement of pain threshold-raising action of aspirin, codeine, and meperidine (Demerol). Fed. Proc. 9:282 (March) 1950.
- American Dental Association: Accepted Dental Remedies. Chicago, American Dental Association, 1957, p. 12.
- Paul, W. D., Dryer, R. L. and Routh, J. I.: Effects of buffering agents on absorption of acetylsalicylic acid. J. Am. Pharm. A. 39:21–24 (January) 1950.
- Tebrock, H. E.: Gastric tolerance for aspirin and buffered aspirin. Indust. Med. 20:480–482 (October) 1951.
- Fremont-Smith, P.: Bufferin in the management of rheumatoid arthritis. J.A.M.A. 158:386 (June 4) 1955.
- Batterman, R. C., Grossman, A. J. and Sommer, E.: Influence of antacids on salicylate absorption and clinical effectiveness. Fed. Proc. 15:398 (March) 1956.
- Batterman, R. C.: Comparison of buffered and unbuffered acetvlsalicylic acid. New England J. Med. 258:213–219 (January 30) 1958.
- Cronk, G. A.: Laboratory and clinical studies with buffered and nonbuffered acetylsalicylic acid. New England J. Med. 258:219–221 (January 30) 1958.